LB
40
-4
APH
58
2
EL
52
-10
WEC
39
-2
T
35
2
HSY
37
2
COST
48
-8
WFC
71
2
CCI
36
2
WDC
63
3
HD
41
6
ABBV
57
-2
MSI
46
-3
UPS
32
-6
FOX
57
2
ZBH
56
11
ITW
37
-2
CPB
37
-2
PSA
53
-3
GT
41
-13
LB
40
-4
APH
58
2
EL
52
-10
WEC
39
-2
T
35
2
HSY
37
2
COST
48
-8
WFC
71
2
CCI
36
2
WDC
63
3
HD
41
6
ABBV
57
-2
MSI
46
-3
UPS
32
-6
FOX
57
2
ZBH
56
11
ITW
37
-2
CPB
37
-2
PSA
53
-3
GT
41
-13
Financhill
Back

Tango Therapeutics, Inc. 10K Form

Buy
63

TNGX
Tango Therapeutics, Inc.

Last Price:
$9.89
Seasonality Move:
-5.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TNGX News And Ratings

See the #1 stock for the next 7 days that we like better than TNGX

TNGX Financial Statistics

Sales & Book Value

Annual Sales: $42.1M
Cash Flow: $-31.1M
Price / Cash Flow: 0
Annual Sales: $1.43
Price / Book: 8.05

Profitability

EPS (TTM): -0.91650
Net Income (TTM): $-100.5M
Gross Margin: $39.6M
Return on Equity: -56.44%
Return on Assets: -35.8%

Tango Therapeutics, Inc. Earnings Forecast

Key Tango Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 5 years for TNGX is 94.06%.
  • The Selling, General & Administrative Expenses for TNGX have been equal to 103.99% of Gross Profit Margin.
  • The Research & Development expenses have been 342.10% of Revenue.
  • The Net Earning history of TNGX is -309.73% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Tango Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TNGX
Website: tangotx.com

Debt

Debt-to-Equity Ratio: 0.22
Current Ratio: 8.88
Quick Ratio: 8.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TNGX Technical Analysis vs Fundamental Analysis

Buy
63
Tango Therapeutics, Inc. (TNGX) is a Buy

Is Tango Therapeutics, Inc. a Buy or a Sell?